IN BRIEF: Belluscura shares up on distribution contract win

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Belluscura PLC - Medical device developer focused on lightweight and portable oxygen enrichment technology - Signs distribution agreement McKesson Medical-Surgical, a subsidiary of McKesson Corp. Says that McKesson delivers a third of all pharmaceuticals used in North America and operates the fourth-largest pharmacy chain in North America. The X-PLOR portable oxygen concentrator will now be available to McKesson’s customers through its online catalogue, it notes.

Chief Executive Robert Rauker says: ‘We are very pleased that McKesson, one of the largest distributors of pharmaceuticals and medical devices in North America, has chosen the X-PLOR to be offered through their catalogue. This significant distribution agreement will mean that more Americans can purchase our devices throughout the country, broadening our product distribution and making supplemental oxygen more easily accessible.’

Current stock price: 36.59 pence, up 6.1% on Tuesday

12 month change: down 60%

Copyright 2023 Alliance News Ltd. All Rights Reserved.